Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 2, 2005, Pages 134-139

  Honkanen, Helena ^a   Ranta, Sirpa ^b   Ylikorkala, Olavi ^a   Heikinheimo, Oskari ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Estradiol; Leptin; Mifepristone; Misoprostol; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HYDROCORTISONE; LEPTIN; MIFEPRISTONE; MISOPROSTOL; PROGESTERONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUTEOLYSIS; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REBOUND; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; COHORT STUDIES; CORPUS LUTEUM; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HUMANS; LEPTIN; MIFEPRISTONE; MISOPROSTOL; MONITORING, PHYSIOLOGIC; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY, UNWANTED; PROBABILITY; PROGESTERONE; RADIOIMMUNOASSAY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 14044251427     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00626.x     Document Type: Article

References (26)

1. Cella F, Giordano G, Cordera R. Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol 2000; 142: 174-8.
2. Messinis IE, Papageorgiou I, Milingos S, Asprodini E, Kollios G, Seferiadis K. Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod 2001; 16: 1827-32.
3. Messinis IE, Kariotis I, Milingos S, Kollios G, Seferiadis K. Treatment of normal women with oestradiol plus progesterone prevents the decrease of leptin concentrations induced by ovariectomy. Hum Reprod 2000; 15: 2383-7.
4. Elbers JM, de Roo GW, Popp-Snijders C, Nicolaas-Merkus A, Westerveen E, Joenje BW et al. Effects of administration of 17beta-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol 1999; 51: 449-54.
5. Lavoie HB, Taylor AE, Sharpless JL, Anderson EJ, Strauss CC, Hall JE. Effects of short-term hormone replacement on serum leptin levels in postmenopausal women. Clin Endocrinol 1999; 51: 415-22.
6. Cento RM, Proto C, Spada RS, Napolitano V, Ciampelli M, Cucinelli F et al. Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 1999; 52: 269-73.
7. Salbach B, Nawroth PP, Kubler W, von Holst T, Salbach PB. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. Eur J Med Res 2000; 5: 63-6.
8. Laivuori H, Koistinen HA, Karonen SL, Cacciatore B, Ylikorkala O. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women. Hum Reprod 2001; 16: 1632-5.
9. Unkila-Kallio L, Andersson S, Koistinen HA, Karonen SL, Ylikorkala O, Tiitinen A. Leptin during assisted reproductive cycles: the effect of ovarian stimulation and of very early pregnancy. Hum Reprod 2001; 16: 657-62.
10. Hardie L, Trayhurn P, Abramovich D, Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clin Endocrinol 1997; 47: 101-6.
11. Stock SM, Sande EM, Bremme KA. Leptin levels vary significantly during the menstrual cycle, pregnancy, and in vitro fertilization treatment: possible relation to estradiol. Fertil Steril 1999; 72: 657-62.
12. Lage M, Garcia-Mayor RV, Tome MA, Cordido F, Valle-Inclan F, Considine RV et al. Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion. Clin Endocrinol 1999; 50: 211-6.
13. Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S. Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Arch Gen Psychiatry 1998; 55: 995-1000.
14. von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I. Efficacy. BJOG 2003; 110: 808-18.
15. Honkanen H, Ranta S, Ylikorkala O, Heikinheimo O. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod 2002; 17: 2315-9.
16. Sufi SB, Donaldson A, Jeffcoate SL. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Programme for the provision of matched assay reagents for the radioimmunoassay of hormones in reproductive physiology. Method manual. London, 1991.
17. Sivan E, Whittaker PG, Sinha D, Homko CJ, Lin M, Reece EA et al. Leptin in human pregnancy: the relationship with gestational hormones. Am J Obstet Gynecol 1998; 179: 1128-32.
18. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998; 178: 1010-5.
19. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996; 45: 984-7.
20. Ottander U, Leung CH, Olofsson JI. Functional evidence for divergent receptor activation mechanisms of luteotrophic and luteolytic events in the human corpus luteum. Mol Hum Reprod 1999; 5: 391-5.
21. Cioffi JA, van Blerkom J, Antczak M, Shafer A, Wittmer S, Snodgrass HR. The expression of leptin and its receptors in preovulatory human follicles. Mol Hum Reprod 1997; 3: 467-72.
22. Kronfeld-Schor N, Zhao J, Silvia BA, Bicer E, Mathews PT, Urban R et al. Steroid-dependent up-regulation of adipose leptin secretion in vitro during pregnancy in mice. Biol Reprod 2000; 63: 274-80.
23. Bertagna X, Bertagna C, Luton JP, Husson JM, Girard F. The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 1984; 59: 25-8.
24. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 1984; 81: 3879-82.
25. Kitawaki J, Koshiba H, Ishihara H, Kusuki I, Tsukamoto K, Honjo H et al. Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle. J Clin Endocrinol Metab 2000; 85: 1946-50.
26. Tanaka T, Utsunomiya T, Bai T, Nakajima S, Umesaki N. Leptin inhibits decidualization and enhances cell viability of normal human endometrial stromal cells. Int J Mol Med 2003; 12: 95-8.